Affimed
(NASDAQ:AFMD)
$8.18
1.65[25.27%]
Last update: 11:27AM Get Real Time Here
Q1 2024 earnings were released today before the market open
Today's conference call ended over 7 hours ago Click to view the webcast
Consensus Rating1
Overweight
Highest Price Target1
$25.00
Lowest Price Target1
$5.00
Consensus Price Target1
$7.89

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Affimed NV has a consensus price target of $7.89, established from looking at the 28 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Wells Fargo, and Cantor Fitzgerald on June 3, 2024, April 1, 2024, and April 1, 2024. With an average price target of $11.67 between HC Wainwright & Co., Wells Fargo, and Cantor Fitzgerald, there's an implied 42.62% upside for Affimed NV from these 3 analyst ratings.

Analyst Trend
2
Apr
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Wells Fargo
Cantor Fitzgerald
Stifel
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Affimed

Buy NowGet Alert
06/03/2024Buy Now22.25%HC Wainwright & Co.
Swayampakula Ramakanth
$10 → $10ReiteratesBuy → BuyGet Alert
04/01/2024Buy Now205.62%Wells Fargo
Yanan Zhu
$30 → $25MaintainsOverweightGet Alert
04/01/2024Buy NowCantor Fitzgerald
Li Watsek
Reiterates → OverweightGet Alert
04/01/2024Buy Now-38.88%Stifel
Bradley Canino
$1 → $5MaintainsHoldGet Alert
04/01/2024Buy Now22.25%HC Wainwright & Co.
Swayampakula Ramakanth
$5 → $10MaintainsBuyGet Alert
11/15/2023Buy Now-38.88%HC Wainwright & Co.
Swayampakula Ramakanth
→ $50ReiteratesBuy → BuyGet Alert
09/25/2023Buy Now-14.43%Cantor Fitzgerald
Li Watsek
→ $70ReiteratesOverweight → OverweightGet Alert
09/12/2023Buy Now-14.43%Cantor Fitzgerald
Li Watsek
→ $70ReiteratesOverweight → OverweightGet Alert
09/07/2023Buy Now-14.43%Cantor Fitzgerald
Li Watsek
→ $70ReiteratesOverweight → OverweightGet Alert
08/11/2023Buy Now-26.65%Truist Securities
Srikripa Devarakonda
$80 → $60MaintainsBuyGet Alert
08/11/2023Buy Now-38.88%HC Wainwright & Co.
Swayampakula Ramakanth
→ $50ReiteratesBuy → BuyGet Alert
08/08/2023Buy Now-26.65%Berenberg
Andy Chen
→ $60Assumes → BuyGet Alert
06/05/2023Buy Now-38.88%HC Wainwright & Co.
Swayampakula Ramakanth
$60 → $50MaintainsBuyGet Alert
05/24/2023Buy Now-26.65%HC Wainwright & Co.
Swayampakula Ramakanth
→ $60ReiteratesBuy → BuyGet Alert
03/27/2023Buy Now-14.43%Wells Fargo
Yanan Zhu
→ $70Assumes → OverweightGet Alert
03/24/2023Buy Now-87.78%Stifel
Bradley Canino
$20 → $10MaintainsHoldGet Alert
03/24/2023Buy Now-26.65%HC Wainwright & Co.
Swayampakula Ramakanth
→ $60Reiterates → BuyGet Alert
12/12/2022Buy Now-14.43%Wells Fargo
James Shin
$80 → $70MaintainsOverweightGet Alert
12/12/2022Buy Now-26.65%Piper Sandler
Do Kim
$70 → $60MaintainsOverweightGet Alert
12/12/2022Buy Now-26.65%SVB Leerink
Daina Graybosch
$100 → $60MaintainsOutperformGet Alert
12/12/2022Buy Now-26.65%HC Wainwright & Co.
Swayampakula Ramakanth
→ $60Initiates → BuyGet Alert
10/10/2022Buy Now-75.55%Stifel
Bradley Canino
$90 → $20DowngradeBuy → HoldGet Alert
06/23/2022Buy Now10.02%SVB Leerink
Daina Graybosch
$100 → $90MaintainsOutperformGet Alert
03/31/2022Buy Now-14.43%Piper Sandler
Do Kim
→ $70Initiates → OverweightGet Alert
02/23/2022Buy Now46.7%Cantor Fitzgerald
Li Watsek
→ $120Initiates → OverweightGet Alert
10/21/2021Buy Now22.25%Truist Securities
Srikripa Devarakonda
→ $100Initiates → BuyGet Alert
10/12/2021Buy Now46.7%SVB Leerink
Daina Graybosch
$130 → $120MaintainsOutperformGet Alert
09/30/2021Buy Now46.7%Stifel
Bradley Canino
→ $120Initiates → BuyGet Alert

FAQ

Q

What is the target price for Affimed (AFMD) stock?

A

The latest price target for Affimed (NASDAQ:AFMD) was reported by HC Wainwright & Co. on June 3, 2024. The analyst firm set a price target for $10.00 expecting AFMD to rise to within 12 months (a possible 22.25% upside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ:AFMD) was provided by HC Wainwright & Co., and Affimed reiterated their buy rating.

Q

When was the last upgrade for Affimed (AFMD)?

A

There is no last upgrade for Affimed

Q

When was the last downgrade for Affimed (AFMD)?

A

The last downgrade for Affimed NV happened on October 10, 2022 when Stifel changed their price target from $9 to $2 for Affimed NV.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on June 3, 2024 so you should expect the next rating to be made available sometime around June 3, 2025.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $10.00 to $10.00. The current price Affimed (AFMD) is trading at is $8.18, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.